Specialist expertise for complex innovation.
Women’s-health innovation cannot be understood through a single lens.
Assessing an early-stage healthcare company may require understanding the underlying science, clinical need, regulatory pathway, reimbursement environment, commercial model, operational capability and financing strategy.
FemTech Capital brings together subject-matter experts across these disciplines to help us understand innovation more deeply—and help promising companies address the gaps between strong science and scalable businesses.
Clinical & Scientific
Clinicians, researchers, scientists and women’s-health specialists who can contribute perspectives on unmet need, clinical relevance, scientific evidence and emerging approaches.
Regulatory & Market Access
Regulatory, quality, clinical development, reimbursement and market-access specialists who understand pathways required to bring healthcare innovation to market.
Operational & Commercial
Experienced founders, executives and operators with expertise across product, go-to-market, healthcare partnerships, enterprise sales, commercialization and international growth.
Capital & Finance
Investors, CFOs and finance professionals with experience in company building, financing strategy, capital readiness and healthcare economics.
FROM EXPERTISE TO BETTER ASSESSMENT
Experts may contribute across the FTC model.
SOURCE → ASSESS → DERISK → SCORE → CONNECT → CREATE VALUE
Depending on the engagement, experts may help FTC understand a technology or clinical area, contribute to company assessment, mentor founders against identified gaps, participate in educational initiatives or support companies as specialist Operating Partners.
MORE THAN MENTORSHIP
For founders, the Expert Network provides access to people capable of challenging assumptions and strengthening companies.
For investors, it contributes specialist perspectives on innovation that may sit outside a generalist investment team’s internal expertise.
For the broader ecosystem, it creates a mechanism through which clinical, scientific, regulatory, operational and financial knowledge can contribute to advancing women’s-health innovation.
Expert participation does not constitute endorsement of any company, security or investment opportunity.